Royal Bank of Canada’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-125,000
Closed -$35.3M 7129
2025
Q3
$35.3M Buy
+125,000
New +$36.3M 0.01% 1217
2024
Q4
Sell
-80,000
Closed -$25.8M 6870
2024
Q3
$25.8M Buy
+80,000
New +$26.2M 0.01% 1190
2019
Q4
Sell
-61,300
Closed -$11.9M 6781
2019
Q3
$11.9M Buy
61,300
+60,600
+8,657% +$11.6M ﹤0.01% 1444
2019
Q2
$129K Sell
700
-300
-30% -$53.7K ﹤0.01% 4746
2019
Q1
$190K Buy
1,000
+600
+150% +$115K ﹤0.01% 4387
2018
Q4
$78K Buy
+400
New +$78K ﹤0.01% 4855
2018
Q3
Sell
-43,500
Closed -$8.03M 6684
2018
Q2
$8.03M Buy
+43,500
New +$7.69M ﹤0.01% 1682
2018
Q1
Sell
-5,900
Closed -$1.03M 6303
2017
Q4
$1.03M Sell
5,900
-1,900
-24% -$336K ﹤0.01% 3212
2017
Q3
$1.45M Hold
7,800
﹤0.01% 2919
2017
Q2
$1.34M Sell
7,800
-385,300
-98% -$62.7M ﹤0.01% 2888
2017
Q1
$64.5M Buy
393,100
+374,600
+2,025% +$62.2M 0.03% 412
2016
Q4
$2.71M Sell
18,500
-2,500
-12% -$376K ﹤0.01% 2357
2016
Q3
$3.5M Sell
21,000
-7,700
-27% -$1.3M ﹤0.01% 2149
2016
Q2
$4.37M Sell
28,700
-19,000
-40% -$2.95M ﹤0.01% 1982
2016
Q1
$7.15M Buy
+47,700
New +$7.09M ﹤0.01% 1581
2015
Q1
Sell
-66,600
Closed -$10.6M 6099
2014
Q4
$10.6M Sell
66,600
-12,300
-16% -$1.92M 0.01% 1196
2014
Q3
$11.1M Buy
78,900
+11,600
+17% +$1.51M 0.01% 1154
2014
Q2
$7.97M Buy
67,300
+45,900
+214% +$5.31M 0.01% 1347
2014
Q1
$2.64M Buy
+21,400
New +$2.6M ﹤0.01% 2050

Other funds holding AMGN

Royal Bank of Canada's AMGN Position: Q1 2026 in Review

Royal Bank of Canada reduced its Amgen (AMGN) stake by 5% in Q1 2026, selling an estimated $83.2M and leaving 4,471,445 shares worth $1.57B. The position accounts for 0.28% of the portfolio, ranked #68.

Royal Bank of Canada first reported a position in AMGN in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.68B in Q4 2023. 3,137 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Royal Bank of Canada held 4,471,445 shares of Amgen worth $1.57B as of Q1 2026.
  • Royal Bank of Canada sold 233,485 Amgen shares in Q1 2026, an estimated $83.2M.
  • Amgen made up 0.28% of Royal Bank of Canada's portfolio in Q1 2026, its #68 holding.
  • Royal Bank of Canada first reported a position in Amgen in Q2 2013 and has held it in 52 quarters since.
  • Royal Bank of Canada's Amgen position peaked at $1.68B in Q4 2023.
  • 3,137 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.